Related Experiment Video
Updated: Oct 26, 2025

06:07
Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
2.6K
Considerations for successful therapeutic immunization in HIV cure
Beatriz Mothe1,2,3, Christian Brander2,3,4,5
1Fundació Lluita Contra La Sida, Infectious Diseases Department.
Current Opinion in HIV and AIDS
|July 26, 2021
Summary
Therapeutic immunization and broadly neutralizing antibodies show promise for controlling human immunodeficiency virus (HIV) without antiretroviral therapy. While challenges remain in eliminating the viral reservoir, these strategies offer a path toward HIV remission.
Area of Science:
- Immunology
- Virology
- Infectious Diseases
Background:
- Human immunodeficiency virus (HIV) cure research is a critical area of study.
- Antiretroviral therapy (ART) manages HIV but does not eliminate the virus.
- Therapeutic immunization strategies aim to control HIV without ART.
Purpose of the Study:
- To review the role of therapeutic immunization in HIV cure strategies.
- To assess methods for eliminating HIV-infected cells.
- To evaluate strategies for sustained viral control off ART.
Main Methods:
- Review of recent data from simian immunodeficiency virus (SIV) macaque models.
- Analysis of human clinical studies with novel therapeutic vaccines.
- Investigation of broadly neutralizing antibodies (bNAbs) and immunomodulatory agents.
Main Results:
- Studies in SIV models and human trials show encouraging results.
- Broadly neutralizing antibodies and therapeutic vaccines demonstrate potential for viral remission.
- Partial viral control of HIV without ART appears feasible.
Conclusions:
- Emerging results suggest that HIV remission or control without ART is achievable.
- Current strategies need further improvement to effectively target the viral reservoir.
- Therapeutic immunization and bNAbs represent promising avenues for HIV cure research.
Related Concept Videos
Retrovirus Life Cycles
47.8K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.8K
Tumor Immunotherapy
778
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
778
Vaccinations
47.3K
Overview
47.3K
Cancer Vaccines
581
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
581
Development of Immunocompetence
533
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
533
Immunodeficiency Diseases
1.3K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.3K

